[INHIBITION OF PHOSPHOKINASES BY THE 6-AMINONICOTINAMIDE ANALOG (6 ANAD) OF NICOTINE-ADENINE-DINUCLEOTIDE (NAD)]
Side Effects & Safety Mild GI discomfort most common, usually transient in the first week Slight stimulant effect increased energy/alertness, especially early on Headaches occasional, typically mild and dose-related Mild insomnia if taken too late in the day No human clinical safety data all safety information from preclinical studies and community reports No liver toxicity observed in animal studies at therapeutic doses Unknown drug interactions theoretically could interact with NAD+-dependent pathways Core Supplies for This Protocol The essentials for running any reconstituted injectable: cold storage, accurate syringes, alcohol prep pads, and metabolic tracking
Long-term deficiency can damage the protective myelin around nerves, and if it is not addressed, some of that damage can become permanent, causing numbness, pain, and balance problems
Its inhibition restores NAD+ levels, reduces lipogenesis, and improves insulin sensitivity
Prioritize 7-9 hours of quality sleep
Provider review is included